Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future

被引：0
|
作者：
Rajappan, Kim [1 ]
机构：
[1] John Radcliffe Hosp, Dept Cardiac, Oxford OX3 9DU, England
来源：
HEART | 2013年 / 99卷 / 06期
关键词：
RISK; WARFARIN;
D O I：
10.1136/heartjnl-2012-302762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 362
页数：2
相关论文
共 50 条
  • [31] Novel Anticoagulants in Secondary Stroke Prevention after TIA or Minor Stroke in Patients with Atrial Fibrillation
    Diener, Hans-Christoph
    CEREBROVASCULAR DISEASES, 2013, 36 : 8 - 8
  • [32] Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus
    Li, Y. -G.
    Pastori, D.
    Lip, G. Y. H.
    DIABETIC MEDICINE, 2018, 35 (08) : 1134 - 1135
  • [33] Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence
    Martinez-Rubio, Antoni
    Andrei Dan, George
    Carlos Kaski, Juan
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (08) : 933 - 947
  • [34] Cost-effectiveness of apixaban against other novel oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation patients
    Lip, G. H. Y.
    Kongnakorn, T.
    Phatak, H.
    Kuznik, A.
    Rublee, D.
    Lanitis, T.
    Liu, L.
    Iloeje, U.
    Dorian, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 54 - 54
  • [35] Practical Considerations in the Use of Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Deitelzweig, Steven
    CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 74 - 81
  • [36] Novel Anticoagulants in Prevention of Cardioembolic Stroke in Patiens with Non-Valvular Atrial Fibrillation
    Bauer, Jiri
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 (05) : 550 - 558
  • [37] Clinical Challenges of Using Novel Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
    Nazeri, Alireza
    TEXAS HEART INSTITUTE JOURNAL, 2018, 45 (03) : 164 - 165
  • [38] Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation
    Lee, Hyun-Jung
    Kim, Hyung-Kwan
    Jung, Jin-Hyung
    Han, Kyung-Do
    Lee, Heesun
    Park, Jun-Bean
    Kim, Hyue Mee
    Kim, Yong-Jin
    Ommen, Steve R.
    STROKE, 2019, 50 (09) : 2582 - 2586
  • [39] Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
    Charalampos Kasmeridis
    Stavros Apostolakis
    Lars Ehlers
    Lars H. Rasmussen
    Giuseppe Boriani
    Gregory Y. H. Lip
    PharmacoEconomics, 2013, 31 : 971 - 980
  • [40] Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
    Kasmeridis, Charalampos
    Apostolakis, Stavros
    Ehlers, Lars
    Rasmussen, Lars H.
    Boriani, Giuseppe
    Lip, Gregory Y. H.
    PHARMACOECONOMICS, 2013, 31 (11) : 971 - 980
12345